<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02678962</url>
  </required_header>
  <id_info>
    <org_study_id>MIOLs2016</org_study_id>
    <nct_id>NCT02678962</nct_id>
  </id_info>
  <brief_title>Comparison of Outcomes With Multifocal Intraocular Lenses</brief_title>
  <acronym>COMIL</acronym>
  <official_title>Comparison of Outcomes With Multifocal Intraocular Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wenzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wenzhou Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare and evaluate the clinical outcomes of 6 kinds of
      Multifocal Intraocular Lenses: SN6AD1, SBL-3, LS-313 MF30, AT LISA tri 839 MP, ART, LS-313
      MF30T.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a prospective randomized controlled trial to compare and evaluate the clinical
      outcomes of 6 kinds of Multifocal Intraocular Lenses, the outcome measurements include
      postoperative visual acuity, visual quality and complications. Patients enrolled in the study
      will be randomized to receive one of the Multifocal Intraocular Lenses mentioned above, and
      the clinical outcomes of each Multifocal Intraocular Lens will be assessed at several visits:
      1 day, 1 week, 1 month, 3 months and months post-operatively.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Uncorrected Visual Acuity (UCVA) at Distance, Near</measure>
    <time_frame>3 months after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Best distance corrected Visual Acuity at Distance, Near</measure>
    <time_frame>3 months after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Defocus curve</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>measured with distance correction for unilateral and bilateral</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Contrast sensitivity</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>measured with CSV-1000HGT(VECTOR VISION, Greenville, OH)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ocular aberration</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>measured with a custom-built aberrometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ocular Scatter Index measured by Optical Quality Analysis System(OQAS) II</measure>
    <time_frame>3 months after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Modulation Transfer Function (MTF) cut-off measured by OQAS II</measure>
    <time_frame>3 months after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Strehl Ratio measured by OQAS II</measure>
    <time_frame>3 months after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of Vision (QoV) Questionnaire score</measure>
    <time_frame>3 months after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Catquest- 9SF Questionnaire score</measure>
    <time_frame>3 months after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Refractive error after surgery</measure>
    <time_frame>3 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Posterior Capsule Opacification</measure>
    <time_frame>6 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Nd:YAG Laser Posterior Capsulotomy</measure>
    <time_frame>6 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Spectacle Independence</measure>
    <time_frame>6 months after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>SN6AD1 group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bilateral cataract surgery with implantation of SN6AD1 multifocal IOLs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SBL-3 group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bilateral cataract surgery with implantation of SBL-3 multifocal IOLs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LS-313 MF30 group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bilateral cataract surgery with implantation of LS-313 MF30 multifocal IOLs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AT LISA tri 839 MP group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bilateral cataract surgery with implantation of AT LISA tri 839 MP multifocal IOLs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ART group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bilateral cataract surgery with implantation of ART toric multifocal IOLs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LS-313 MF30T group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bilateral cataract surgery with implantation of LS-313 MF30T toric multifocal IOLs</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SN6AD1</intervention_name>
    <description>Bilateral cataract surgery with implantation of SN6AD1 multifocal IOLs</description>
    <arm_group_label>SN6AD1 group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SBL-3</intervention_name>
    <description>Bilateral cataract surgery with implantation of SBL-3 multifocal IOLs</description>
    <arm_group_label>SBL-3 group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LS-313 MF30</intervention_name>
    <description>Bilateral cataract surgery with implantation of LS-313 MF30 multifocal IOLs</description>
    <arm_group_label>LS-313 MF30 group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AT LISA tri 839 MP</intervention_name>
    <description>Bilateral cataract surgery with implantation of AT LISA tri 839 MP multifocal IOLs</description>
    <arm_group_label>AT LISA tri 839 MP group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ART</intervention_name>
    <description>Bilateral cataract surgery with implantation of ART toric multifocal IOLs</description>
    <arm_group_label>ART group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LS-313 MF30T</intervention_name>
    <description>Bilateral cataract surgery with implantation of LS-313 MF30T toric multifocal IOLs</description>
    <arm_group_label>LS-313 MF30T group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age from 40 to 80 years old, either gender;

          -  Patients with bilateral age related cataracts, require bilateral cataract
             phacoemulsification combined Intraocular Lens implantation;

          -  Willing to undergo second eye surgery within 7 days after first eye surgery;

          -  The potential postoperative visual acuity of 20/40 or better in both eyes;

          -  Preoperative measurement of corneal astigmatism indicate the subjects are suitable for
             multifocal intraocular lenses implantation;

          -  Capability to understand the informed consent and willing and able to attend study

        Exclusion Criteria:

          -  Preexisting ocular diseases or conditions other than age related cataracts, have
             contraindications for cataract surgery;

          -  Preexisting systemic diseases or conditions that may confound the results of the
             study;

          -  Previous ocular surgery history or ocular trauma that may confound the results of the
             study;

          -  Require combined surgery that may confound the results of the study;

          -  Previous participation in other clinical trial within 30 days of this study start;

          -  Systemic or ocular medications that may confound the outcome of the intervention

          -  Pregnant, lactating, or planning to become pregnant during the course of the trial;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AYong Yu, MD. PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wenzhou Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>AYong Yu, MD. PhD.</last_name>
    <phone>+86-0577-88068880</phone>
    <email>yaybetter@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Eye Hispital of Wenzhou Medical University</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anpeng Pan, MD.OD.</last_name>
      <phone>+86-577-88068809</phone>
      <email>pananpeng@126.com</email>
    </contact>
    <investigator>
      <last_name>Shuangqian Zhu, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kaijing Zhou, MD.PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2016</study_first_submitted>
  <study_first_submitted_qc>February 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2016</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wenzhou Medical University</investigator_affiliation>
    <investigator_full_name>A-Yong Yu</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Multifocal Intraocular Lenses</keyword>
  <keyword>bilateral implantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

